Marico Limited Q2 FY27 Performance Overview

!MARICO -- Key Financial Highlights -- ** (Consolidated)Revenue from Operations: Stood at ₹3,897 crores for Q2 FY27, marking an increase compared to ₹3,450 crores in the corresponding quarter of the previous year. For the half year ended September 30, 2026, revenue reached ₹7,854 crores. ** Net Profit: The net profit for the quarter was reported at ₹558 crores, compared to ₹432 crores in Q2 FY25/26 comparative periods, while half-year net profit stood at ₹1,210 crores. ** Segment Performance:India Business: Recorded segment revenue of ₹2,916 crores and segment results (profit before tax and interest) of ₹540 crores for the quarter. **International Business: Contributed robust revenue of ₹981 crores and segment results of ₹217 crores for the quarter. --- Corporate Developments & Strategic UpdatesLeadership Appointment --- The Board of Directors approved the appointment of Mr. Rajan Bharti Mittal as the Lead Independent Director effective November 2, 2026. ** Subsidiary Integration (Beardo): The business undertaking of Zed Lifestyle Private Limited ("Beardo") was integrated into the parent company via voluntary liquidation on a going concern basis effective June 29, 2026. ** International Acquisition: Marico South East Asia Corporation acquired a 75% stake in Skinetiq Joint Stock Company (owner of the "Candid" brand and distributor of "Murad" in Vietnam) effective April 2, 2026. ** Increased Stake in Plix: Subsequent to the quarter end, Marico entered into definitive agreements on October 5, 2026, to increase its stake in Satiya Nutraceuticals Private Limited ("Plix") to 84.09% on a fully diluted basis, with the remaining tranche scheduled for July 2027. Disclosure /Disclaimer Link: *****